Readoutin 75d
Janssen Research & Development, LLC — Icotrokinra
Phase 3 primary completion: A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis.
- Date
- Feb 2027
- Type
- Readout
- Indication
- Arthritis, Psoriatic